Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu'ning Song

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|July 18, 2013
Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activitiesYu'ning Song, Peng Zhan, Xinyong Liu
Current Pharmaceutical Design|November 8, 2012
Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistryYu'ning Song, Peng Zhan, Qingzhu Zhang, et al.
Current Medicinal Chemistry|October 30, 2013
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 updateYu'ning Song, Zengjun Fang, Peng Zhan, et al.
Molecular Biosystems|September 12, 2014
Recent advances in the structure-based rational design of TNKSIsPeng Zhan, Yu'ning Song, Yukihiro Itoh, et al.
Molecular Biosystems|May 21, 2014
"Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targetsDongwei Kang, Yu'ning Song, Wenmin Chen, et al.
Future Medicinal Chemistry|June 26, 2014
Conformational restriction: an effective tactic in 'follow-on'-based drug discoveryZengjun Fang, Yu'ning Song, Peng Zhan, et al.
Expert Opinion on Therapeutic Patents|October 15, 2014
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)Xiao Li, Lingzi Zhang, Ye Tian, et al.
Combinatorial Chemistry & High Throughput Screening|January 23, 2014
"Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refiningYu'ning Song, Wenmin Chen, Dongwei Kang, et al.
Current Medicinal Chemistry|November 3, 2012
Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discoveryYu'ning Song, Peng Zhan, Xiao Li, et al.
European Journal of Medicinal Chemistry|June 13, 2014
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidateYu'ning Song, Xiaoqian Lin, Dongwei Kang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|July 18, 2013
Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activitiesYu'ning Song, Peng Zhan, Xinyong Liu
Current Pharmaceutical Design|November 8, 2012
Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistryYu'ning Song, Peng Zhan, Qingzhu Zhang, et al.
Current Medicinal Chemistry|October 30, 2013
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 updateYu'ning Song, Zengjun Fang, Peng Zhan, et al.
Molecular Biosystems|September 12, 2014
Recent advances in the structure-based rational design of TNKSIsPeng Zhan, Yu'ning Song, Yukihiro Itoh, et al.
Molecular Biosystems|May 21, 2014
"Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targetsDongwei Kang, Yu'ning Song, Wenmin Chen, et al.
Future Medicinal Chemistry|June 26, 2014
Conformational restriction: an effective tactic in 'follow-on'-based drug discoveryZengjun Fang, Yu'ning Song, Peng Zhan, et al.
Expert Opinion on Therapeutic Patents|October 15, 2014
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)Xiao Li, Lingzi Zhang, Ye Tian, et al.
Combinatorial Chemistry & High Throughput Screening|January 23, 2014
"Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refiningYu'ning Song, Wenmin Chen, Dongwei Kang, et al.
Current Medicinal Chemistry|November 3, 2012
Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discoveryYu'ning Song, Peng Zhan, Xiao Li, et al.
European Journal of Medicinal Chemistry|June 13, 2014
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidateYu'ning Song, Xiaoqian Lin, Dongwei Kang, et al.
Pageof 1